Haima Therapeutics
Operator of a biotechnology company intended to develop cell-inspired therapies to mitigate bleeding and other blood-related disorders. The company's novel fully-synthetic nanoparticle-based hemostati...
Valuation
$0
Share Price
N/A
Total Raised
$1.1M
Last Round
N/A